• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

What COVID-19 Labs Must Do to Prosper in a Post-Pandemic World

What COVID-19 Labs Must Do to Prosper in a Post-Pandemic World

by Glenn S. Demby | Feb 28, 2023 | Inside the Lab Industry-lir, Laboratory Industry Report

With COVID-19 testing demand all but dried up, labs will have to make—or at least contemplate making—significant changes to their business.

This content is for Paid Members only.
Login Register
How to Explain the Current State of EKRA to Your Lab Executives

How to Explain the Current State of EKRA to Your Lab Executives

by Glenn S. Demby | Feb 24, 2023 | Brief Your CEO-lca, Lab Compliance Advisor, Reimbursement-lca

How to explain the current state of EKRA to your lab executives.

This content is for Paid Members only.
Login Register
Building an Effective Business Case for Your Lab

Building an Effective Business Case for Your Lab

by Scott D. Hanton, PhD | Jan 31, 2023 | Inside the Lab Industry-lir, Laboratory Industry Report

An effective business case communicates need, benefit, and risks.

This content is for Paid Members only.
Login Register
Model Conflict of Interest Policy for Employees Romantically Involved with Co-Workers

Model Conflict of Interest Policy for Employees Romantically Involved with Co-Workers

by Glenn S. Demby | Jan 30, 2023 | Lab Compliance Advisor, Tool

Here’s a template for a conflict of interest policy that you can adapt for your lab based on its specific situation and HR policies.

This content is for Paid Members only.
Login Register
Model Workplace Romance ‘Love Contract’

Model Workplace Romance ‘Love Contract’

by Glenn S. Demby | Jan 30, 2023 | Lab Compliance Advisor, Tool

Having employees involved in office romances disclose their relationship and follow key ground rules can help avoid negative impacts on the lab.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com